Grant: Master's Award: Canada Graduate Scholarships
University of Alberta
$17,500.00
Investigating the Consumption of Gut Metabolites by Crohn's Disease-Associated Escherichia Coli
EF 2022-23
Résumé
Crohn's disease (CD) is an inflammatory bowel disease driven by gut bacteria in genetically susceptible individuals. Adherent invasive strains of Escherichia coli (AIEC) have been recognized as CD risk factors due to their pro-inflammatory traits. By evolving AIEC in the host environment, we have shown that these strains can rapidly acquire mutations that improve their ability to consume short chain fatty acids (SCFA), while increasing their fitness in the gut environment. Given their anti-inflammatory role, the utilization of SCFA by AIEC promotes inflammation. We have recently identified several mutations in an evolved AIEC isolate that rewired its metabolism. This led to a trade-off between the metabolism of SCFA and other carbon sources, allowing AIEC to consume these immunomodulatory molecules. Using transcriptomics, we have identified several transporters that are upregulated in the evolved AIEC lineages, suggesting a potential role in importing SCFA. These data provide key mechanistic insights into the virulence of a CD-associated pathogen.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Alberta, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
485920
Name
Mansour Sarah
Region
Alberta
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Investigating the Consumption of Gut Metabolites by Crohn's Disease-Associated Escherichia Coli
Programtype2
Studentship Programs
Orgnameinp2
University of Alberta
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Adherent-Invasive Escherichia Coli; Crohn'S Disease; Evolution; Gene Regulation; Inflammation; Inflammatory Bowel Disease; Metabolic Adaptation; Metabolism; Short Chain Fatty Acids; Trade-Off
Abstract
Crohn's disease (CD) is an inflammatory bowel disease driven by gut bacteria in genetically susceptible individuals. Adherent invasive strains of Escherichia coli (AIEC) have been recognized as CD risk factors due to their pro-inflammatory traits. By evolving AIEC in the host environment, we have shown that these strains can rapidly acquire mutations that improve their ability to consume short chain fatty acids (SCFA), while increasing their fitness in the gut environment. Given their anti-inflammatory role, the utilization of SCFA by AIEC promotes inflammation. We have recently identified several mutations in an evolved AIEC isolate that rewired its metabolism. This led to a trade-off between the metabolism of SCFA and other carbon sources, allowing AIEC to consume these immunomodulatory molecules. Using transcriptomics, we have identified several transporters that are upregulated in the evolved AIEC lineages, suggesting a potential role in importing SCFA. These data provide key mechanistic insights into the virulence of a CD-associated pathogen.
Competitiondate
202212
Approvedterm2
1 yr 0 mth
Pinamesdelim
Mansour, Sarah
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~